Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients
Authors:
- David B. CaseDCDavid B. Case
- John M. WallaceJWJohn M. Wallace
- Hans J. KeimHKHans J. Keim
- Jean E. SealeyJSJean E. Sealey
- John H. LaraghJLJohn H. Laragh
- 1 May 1976
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 60 (6) , 825-836
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Radioimmunoassay of plasma renin activitySeminars in Nuclear Medicine, 1975
- INFUSION OF ANGIOTENSIN-II ANALOGUE IN TWO PATIENTS WITH UNILATERAL RENOVASCULAR HYPERTENSIONThe Lancet, 1974
- Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulationProgress in Cardiovascular Diseases, 1974
- Low-renin hypertensionKidney International, 1974
- ANGIOTENSIN BLOCKADEThe Lancet, 1974
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973
- Volume factor in low and normal renin essential hypertensionThe American Journal of Cardiology, 1973
- Plasma renin and the antihypertensive effect of 1-Sar-8-Ala-angiotensin IIEuropean Journal of Pharmacology, 1973
- Angiotensin II Vascular Receptors: Their Avidity in Relationship to Sodium Balance, the Autonomic Nervous System, and HypertensionJournal of Clinical Investigation, 1972
- Prolonged Infusions of Angiotensin II and Norepinephrine and Blood Pressure, Electrolyte Balance, and Aldosterone and Cortisol Secretion in Normal Man and in Cirrhosis with Ascites*Journal of Clinical Investigation, 1965